Key result
Diuretic-based hypertension treatment reduced cardiovascular morbidity and mortality, including stroke and coronary heart disease events, compared with placebo or control.
Why the study?
Does diuretic-based treatment reduce cardiovascular morbidity and mortality in patients with hypertension?
Population
Patients with hypertension
Comparison
Diuretic-based treatment vs Placebo or control
Design
Review
Authors
Loading...
Supports diuretic preference in hypertension; leaves open optimal comparisons with contemporary agents.
Does diuretic-based treatment reduce cardiovascular morbidity and mortality in patients with hypertension?
Diuretics remain a preferred initial therapy for hypertension due to their proven efficacy in reducing cardiovascular morbidity, mortality, and related complications.
Marvin Moser (2008) conducted a review in Hypertension. Diuretics vs. Placebo or control was evaluated on Cardiovascular morbidity and mortality. Diuretic-based hypertension treatment reduced cardiovascular morbidity and mortality, including stroke and coronary heart disease events, compared with placebo or control.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: